Literature DB >> 29672179

High-alcohol-content flavored alcoholic beverages (supersized alcopops) should be reclassified to reduce public health hazard.

Matthew E Rossheim1, Dennis L Thombs2, Ryan D Treffers3.   

Abstract

In the US, underage drinkers often consume supersized alcopop - a high-alcohol-content, ready-to-drink flavored alcoholic beverage that is currently regulated as beer. However, calculations in this paper illustrate how the high alcohol by volume and low price of supersized alcopops suggest that they rely on a larger proportion of additives for their alcohol content than permitted to meet the legal definition for beer. From a public safety perspective, it is urgently important that the Alcohol and Tobacco Tax and Trade Bureau assess the formulation of supersized alcopops - specifically, the percent of alcohol in the finished product that is derived from additives. Appropriate reclassification of supersized alcopops as distilled spirits would reduce youth access by resulting in increased price and reduced availability at the retail locations where youth most often obtain alcohol.

Entities:  

Keywords:  Flavored alcoholic beverages (FAB); Four Loko; alcohol reclassification; flavored malt beverages (FMB); supersized alcopops; wine coolers

Mesh:

Year:  2018        PMID: 29672179     DOI: 10.1080/00952990.2018.1460375

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  2 in total

1.  Price of Four Loko in Large U.S. Cities, 2018.

Authors:  Matthew E Rossheim; Dennis L Thombs; Ryan D Treffers; Pamela J Trangenstein; Kayla K McDonald; Reema Ahmad; Sieka S Siklo; Kwynn M Gonzalez-Pons; Sumihiro Suzuki; David H Jernigan
Journal:  Alcohol Clin Exp Res       Date:  2019-05-31       Impact factor: 3.455

2.  Alcohol demand and supersized alcopop consumption among undergraduate college students.

Authors:  Mackenzie L Olson; Matthew E Rossheim; Sadie B Sanders; Ali M Yurasek
Journal:  Exp Clin Psychopharmacol       Date:  2020-09-03       Impact factor: 3.492

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.